Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siri Opsahl Hetlevik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Rheumatology|July 17, 2016
Mixed connective tissue diseaseRagnar Gunnarsson, Siri Opsahl Hetlevik, Vibke Lilleby, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 18, 2019
Preclinical Carotid Atherosclerosis in Patients With Juvenile-Onset Mixed Connective Tissue DiseaseKarolina Skagen, Siri Opsahl Hetlevik, Mahtab Zamani, et al.
Annals of the Rheumatic Diseases|June 11, 2016
Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian studySiri Opsahl Hetlevik, Berit Flatø, Marite Rygg, et al.
The Journal of Rheumatology|March 17, 2019
Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled StudyBirgit Nomeland Witczak, Siri Opsahl Hetlevik, Helga Sanner, et al.
Arthritis Research & Therapy|December 23, 2017
Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort studySilje Reiseter, Ragnar Gunnarsson, Jukka Corander, et al.
The Journal of Rheumatology|August 3, 2018
Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue DiseaseSiri Opsahl Hetlevik, Berit Flatø, Trond Mogens Aaløkken, et al.
Rheumatology International|March 18, 2023
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational studySimon Girmai Berger, Birgit Nomeland Witczak, Silje Reiseter, et al.
Trials|February 18, 2026
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trialSiri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohortIvan Foeldvari, Jens Klotsche, Ozgur Kasapcopur, et al.
Journal of Scleroderma and Related Disorders|June 8, 2026
What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohortIvan Foeldvari, Kathryn Torok, Ozgur Kasapcopur, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Rheumatology|July 17, 2016
Mixed connective tissue diseaseRagnar Gunnarsson, Siri Opsahl Hetlevik, Vibke Lilleby, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 18, 2019
Preclinical Carotid Atherosclerosis in Patients With Juvenile-Onset Mixed Connective Tissue DiseaseKarolina Skagen, Siri Opsahl Hetlevik, Mahtab Zamani, et al.
Annals of the Rheumatic Diseases|June 11, 2016
Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian studySiri Opsahl Hetlevik, Berit Flatø, Marite Rygg, et al.
The Journal of Rheumatology|March 17, 2019
Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled StudyBirgit Nomeland Witczak, Siri Opsahl Hetlevik, Helga Sanner, et al.
Arthritis Research & Therapy|December 23, 2017
Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort studySilje Reiseter, Ragnar Gunnarsson, Jukka Corander, et al.
The Journal of Rheumatology|August 3, 2018
Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue DiseaseSiri Opsahl Hetlevik, Berit Flatø, Trond Mogens Aaløkken, et al.
Rheumatology International|March 18, 2023
Cardiac dysfunction in mixed connective tissue disease: a nationwide observational studySimon Girmai Berger, Birgit Nomeland Witczak, Silje Reiseter, et al.
Trials|February 18, 2026
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trialSiri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohortIvan Foeldvari, Jens Klotsche, Ozgur Kasapcopur, et al.
Journal of Scleroderma and Related Disorders|June 8, 2026
What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohortIvan Foeldvari, Kathryn Torok, Ozgur Kasapcopur, et al.
Pageof 1